PMID- 31118646
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1176-6328 (Print)
IS  - 1178-2021 (Electronic)
IS  - 1176-6328 (Linking)
VI  - 15
DP  - 2019
TI  - Personality associated with depressive status in individuals with type 2 diabetes 
      mellitus.
PG  - 1133-1139
LID - 10.2147/NDT.S200012 [doi]
AB  - Objective: Type 2 diabetes mellitus (T2DM) is associated with a high prevalence 
      of depression, and depression is influenced by personality traits; however, these 
      psychological factors have not been well studied in individuals with T2DM. The 
      association between the use of a 5-factor model of personality and depressive 
      symptoms was examined in individuals with T2DM. Methods: The subjects were 435 
      T2DM patients (mean age 63.1+/-12.6 years). Depressive status and personality 
      traits were assessed using the Center for Epidemiologic Studies Depression Scale 
      and the Ten-Item Personality Inventory, Japanese version, respectively. Lifestyle 
      factors and glycated hemoglobin A1c levels in the patients were also included in 
      the analyses. Results: Among the 435 subjects with T2DM, 130 (29.9%) exhibited 
      possible depression, and 68 (15.6%) exhibited probable depression. After 
      adjustment for confounders, Extraversion, Agreeableness and Neuroticism were 
      found to be significantly associated with the presence of depression. No 
      relationships were found between depression and HbA1c. Conclusion: These findings 
      indicate that Extraversion and Agreeableness are protective factors, and 
      Neuroticism is a risk factor for depression in T2DM patients. Psychological 
      therapy focusing on personality may reduce depressive symptoms. Additional 
      studies are needed to examine the relationships between psychological factors and 
      depressive symptoms using a longitudinal study design.
FAU - Yasui-Furukori, Norio
AU  - Yasui-Furukori N
AD  - Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, 
      Japan.
AD  - Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, 
      Hirosaki, Japan.
FAU - Murakami, Hiroshi
AU  - Murakami H
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Otaka, Hideyuki
AU  - Otaka H
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Nakayama, Hirofumi
AU  - Nakayama H
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Murabayashi, Masaya
AU  - Murabayashi M
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Mizushiri, Satoru
AU  - Mizushiri S
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Matsumura, Koki
AU  - Matsumura K
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Tanabe, Jutaro
AU  - Tanabe J
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Matsuhashi, Yuki
AU  - Matsuhashi Y
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Yanagimachi, Miyuki
AU  - Yanagimachi M
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Nakamura, Kazuhiko
AU  - Nakamura K
AD  - Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, 
      Hirosaki, Japan.
FAU - Daimon, Makoto
AU  - Daimon M
AD  - Department of Endocrinology and Metabolism, Hirosaki University Graduate School 
      of Medicine, Hirosaki, Japan.
FAU - Sugawara, Norio
AU  - Sugawara N
AD  - Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, 
      Japan.
AD  - Department of Clinical Epidemiology, Translational Medical Center, National 
      Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
LA  - eng
PT  - Journal Article
DEP - 20190503
PL  - New Zealand
TA  - Neuropsychiatr Dis Treat
JT  - Neuropsychiatric disease and treatment
JID - 101240304
PMC - PMC6504551
OTO - NOTNLM
OT  - Japanese
OT  - cross-sectional studies
OT  - depressive symptoms
OT  - personality
OT  - type 2 diabetes
COIS- Norio Yasui-Furukori has been a speaker for Dainippon-Sumitomo Pharmaceutical, 
      Mochida Pharmaceutical, MSD and Otsuka Pharmaceutical. The authors report no 
      other conflicts of interest in this work. 
EDAT- 2019/05/24 06:00
MHDA- 2019/05/24 06:01
PMCR- 2019/05/03
CRDT- 2019/05/24 06:00
PHST- 2018/12/31 00:00 [received]
PHST- 2019/04/01 00:00 [accepted]
PHST- 2019/05/24 06:00 [entrez]
PHST- 2019/05/24 06:00 [pubmed]
PHST- 2019/05/24 06:01 [medline]
PHST- 2019/05/03 00:00 [pmc-release]
AID - 200012 [pii]
AID - 10.2147/NDT.S200012 [doi]
PST - epublish
SO  - Neuropsychiatr Dis Treat. 2019 May 3;15:1133-1139. doi: 10.2147/NDT.S200012. 
      eCollection 2019.